These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37566732)

  • 1. Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic review.
    Maghfour J; Shoukfeh R; Hamzavi IH; Ezzedine K; Mohammad TF
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2270-2272. PubMed ID: 37566732
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of camouflage in vitiligo: A cross-sectional survey.
    Poondru S; Kundu RV
    J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement properties of outcome measures for vitiligo. A systematic review.
    Vrijman C; Linthorst Homan MW; Limpens J; van der Veen W; Wolkerstorfer A; Terwee CB; Spuls PI
    Arch Dermatol; 2012 Nov; 148(11):1302-9. PubMed ID: 22986764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis.
    Nathalie J; Chang J; Ezzedine K; Rodrigues M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e755-e756. PubMed ID: 34013610
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the outcome measures used in clinical trials for vitiligo.
    Br J Dermatol; 2023 Feb; 188(2):e17. PubMed ID: 36763883
    [No Abstract]   [Full Text] [Related]  

  • 6. Male genital vitiligo.
    Dauendorffer JN; Skayem C; Passeron T
    Ann Dermatol Venereol; 2022 Jun; 149(2):92-98. PubMed ID: 34226034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo and makeup: analyzing interest and usage trends in the 21st century.
    Syder NC; Elbuluk N
    Int J Dermatol; 2023 Sep; 62(9):e505-e506. PubMed ID: 36691783
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing and managing the mental health of people with vitiligo: a UK-wide consultation exercise.
    Barlow R; Ahmed A; Fellows J; Goulding J; Handley K; Schneider A; Thompson A; Valente M; Waters C; Eleftheriadou V
    Br J Dermatol; 2024 Mar; 190(4):574-576. PubMed ID: 38112664
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcultural assessment of quality of life in patients with vitiligo.
    Hans A; Reddy KA; Black SM; Thomas J; Martinez-Luna O; McKesey J; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2022 May; 86(5):1114-1116. PubMed ID: 33852927
    [No Abstract]   [Full Text] [Related]  

  • 10. Current Status of Cell-Based Therapies for Vitiligo.
    Domaszewska-Szostek A; Polak A; Słupecka-Ziemilska M; Krzyżanowska M; Puzianowska-Kuźnicka M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
    Br J Dermatol; 2023 Oct; 189(5):e94. PubMed ID: 37879743
    [No Abstract]   [Full Text] [Related]  

  • 12. Views and Beliefs of Vitiligo Patients in Online Discussion Forums: A Qualitative Study.
    Gadarowski MB; Bashyam AM; McMichael AJ; Feldman SR
    Cutis; 2022 Jan; 109(1):49-53. PubMed ID: 35180057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review.
    Chan MF; Chua TL
    Int J Nurs Pract; 2012 Aug; 18(4):396-405. PubMed ID: 22845640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
    Daniel SR; Gandhi K; Anastassopoulos KP; Pandya AG; Sikirica V; Patel R; Napatalung L; Yamaguchi Y; Baik R; Ezzedine K
    Br J Dermatol; 2022 Oct; 187(4):603-606. PubMed ID: 35596712
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultra-violet therapy in cases of leucoderma.
    MENON AN
    Ind Med Gaz; 1945 Dec; 80(12):612-4. PubMed ID: 21026566
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical validation and study of stem cell transplantation in treatment of vitiligo.
    Liu J; Liu S; Guo M; Yong M; Hu Z
    Arch Dermatol Res; 2023 Dec; 315(10):2983-2984. PubMed ID: 37676313
    [No Abstract]   [Full Text] [Related]  

  • 17. Global VALIANT study: 'lifting the lid' on disappointment and frustration with the lack of effective treatment for vitiligo.
    Ahmed A; Eleftheriadou V
    Br J Dermatol; 2023 Nov; 189(6):e99-e102. PubMed ID: 37705206
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
    van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
    Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is successful repigmentation in vitiligo from the point of view of patients?
    Narayan VS; Uitentuis SE; Bekkenk MW; Wolkerstorfer A
    Br J Dermatol; 2021 Jan; 184(1):165-166. PubMed ID: 32726875
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the impacts of vitiligo to provide better care.
    Meurant JM
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2161-2162. PubMed ID: 37877765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.